TY - JOUR
T1 - Origin of Chronic Myelocytic Leukemia in a Precursor of Pre-B Lymphocytes
AU - LeBien, Tucker W
AU - Hozier, John
AU - Minowada, Jun
AU - Kersey, John H.
PY - 1979/7/19
Y1 - 1979/7/19
N2 - THE cause of the malignant transformation of hematopoietic cells in human chronic myelocytic leukemia is unknown. However, the demonstration of a characteristic and specific chromosomal rearrangement involving chromosomes 9 and 22,1,2 known as the Philadelphia chromosome, has suggested a common causative factor in this disorder. In addition, studies of the Philadelphia chromosome and the X-linked enzyme glucose-6-phosphate dehydrogenase have implied that the origin of chronic myelocytic leukemia is a monoclonal stem cell.3,4 The studies strongly suggested that, in at least some of these patients, the cellular target of malignant transformation is a progenitor with the potential for differentiation into granulocytes,.
AB - THE cause of the malignant transformation of hematopoietic cells in human chronic myelocytic leukemia is unknown. However, the demonstration of a characteristic and specific chromosomal rearrangement involving chromosomes 9 and 22,1,2 known as the Philadelphia chromosome, has suggested a common causative factor in this disorder. In addition, studies of the Philadelphia chromosome and the X-linked enzyme glucose-6-phosphate dehydrogenase have implied that the origin of chronic myelocytic leukemia is a monoclonal stem cell.3,4 The studies strongly suggested that, in at least some of these patients, the cellular target of malignant transformation is a progenitor with the potential for differentiation into granulocytes,.
UR - http://www.scopus.com/inward/record.url?scp=0018736529&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018736529&partnerID=8YFLogxK
U2 - 10.1056/NEJM197907193010307
DO - 10.1056/NEJM197907193010307
M3 - Article
C2 - 313004
AN - SCOPUS:0018736529
SN - 0028-4793
VL - 301
SP - 144
EP - 147
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 3
ER -